• Exchange: Nasdaq Dubai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Hikma Pharmaceuticals PLC

+ Add to Watchlist


25.299 USD 0.0000.00%

As of 06:00:01 ET on 04/17/2014.

Snapshot for Hikma Pharmaceuticals PLC (HIK)

Open: 25.299 Day's Range: 25.299 - 25.299 Volume: 0
Previous Close: 25.299 52wk Range: 14.440 - 27.669 1-Yr Rtn: +65.35%

Stock Chart for HIK

No chart data available.
  • HIK:DU 25.299
  • 1D
  • 1M
  • 1Y
Interactive HIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HIK

Current P/E Ratio (ttm) 23.5121
Estimated P/E(12/2014) 11.0235
Relative P/E vs. DFMGI 0.0222
Earnings Per Share (USD) (ttm) 1.0760
Est. EPS (USD) (12/2014) 2.2950
Est. PEG Ratio 0.4818
Market Cap (M USD) 2,506.59
Shares Outstanding (M) 99.08
30 Day Average Volume 0
Price/Book (mrq) 4.9255
Price/Sale (ttm) 3.6512
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.1300
Dividend Ex-Date 04/13/2011
5 Year Dividend Growth -
Next Earnings Announcement 08/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HIK

Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing, and marketing a range of both branded and non-branded generic and in-licensed pharmaceutical products. The Company's operations are conducted in the United States, the Middle East, and North Africa region, as well as Europe.

Mazen Samih Taleb DarwazahVice Chairman/CEO:MENASaid Sameeh Talib DarwazahChief Executive Officer
Khalid NabilsiChief Financial OfficerMichael Raya "Mike"President & CEO:US
More Company Profile & Key Executives for HIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil